Logo image of NRM.CA

NORAM LITHIUM CORP (NRM.CA) Stock Fundamental Analysis

TSX-V:NRM - TSX Venture Exchange - CA65542K1030 - Common Stock - Currency: CAD

0.11  -0.01 (-4.35%)

Fundamental Rating

2

NRM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 802 industry peers in the Metals & Mining industry. No worries on liquidiy or solvency for NRM as it has an excellent financial health rating, but there are worries on the profitability. NRM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NRM had negative earnings in the past year.
In the past year NRM has reported a negative cash flow from operations.
NRM had negative earnings in each of the past 5 years.
NRM had a negative operating cash flow in each of the past 5 years.
NRM.CA Yearly Net Income VS EBIT VS OCF VS FCFNRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of NRM (-50.74%) is worse than 64.96% of its industry peers.
NRM has a Return On Equity (-52.65%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -50.74%
ROE -52.65%
ROIC N/A
ROA(3y)-63.24%
ROA(5y)-60.99%
ROE(3y)-68.2%
ROE(5y)-65.73%
ROIC(3y)N/A
ROIC(5y)N/A
NRM.CA Yearly ROA, ROE, ROICNRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

NRM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRM.CA Yearly Profit, Operating, Gross MarginsNRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, NRM has about the same amount of shares outstanding.
NRM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NRM has an improved debt to assets ratio.
NRM.CA Yearly Shares OutstandingNRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NRM.CA Yearly Total Debt VS Total AssetsNRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

An Altman-Z score of 20.05 indicates that NRM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 20.05, NRM belongs to the top of the industry, outperforming 81.67% of the companies in the same industry.
There is no outstanding debt for NRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.05
ROIC/WACCN/A
WACCN/A
NRM.CA Yearly LT Debt VS Equity VS FCFNRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

NRM has a Current Ratio of 4.30. This indicates that NRM is financially healthy and has no problem in meeting its short term obligations.
NRM has a Current ratio of 4.30. This is in the better half of the industry: NRM outperforms 73.82% of its industry peers.
NRM has a Quick Ratio of 4.30. This indicates that NRM is financially healthy and has no problem in meeting its short term obligations.
NRM has a better Quick ratio (4.30) than 74.31% of its industry peers.
Industry RankSector Rank
Current Ratio 4.3
Quick Ratio 4.3
NRM.CA Yearly Current Assets VS Current LiabilitesNRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.71% over the past year.
EPS 1Y (TTM)72.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NRM.CA Price Earnings VS Forward Price EarningsNRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRM.CA Per share dataNRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NRM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORAM LITHIUM CORP

TSX-V:NRM (5/9/2025, 7:00:00 PM)

0.11

-0.01 (-4.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)05-27 2025-05-27
Inst Owners5.91%
Inst Owner ChangeN/A
Ins Owners8.61%
Ins Owner ChangeN/A
Market Cap9.81M
Analysts84.44
Price Target1.16 (954.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB 1.59
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.74%
ROE -52.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-63.24%
ROA(5y)-60.99%
ROE(3y)-68.2%
ROE(5y)-65.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3814.56%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.3
Quick Ratio 4.3
Altman-Z 20.05
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3800.15%
Cap/Depr(5y)2451.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.56%
OCF growth 3YN/A
OCF growth 5YN/A